BAMCO INC /NY/

Position in MRNA — Moderna, Inc.

CIK 1017918 NEW YORK, NY

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$139,316,701

+$138,570,826 QoQ

Shares Held

1,989,386

+26425.1% QoQ

Ownership

0.498%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#26

of 772 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BAMCO INC /NY/ holds $406,272,438 across 24 Biotechnology names. MRNA ranks #1 (34.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	1,989,386	$139,316,701
2	ARGX	Argenx SE	136,654	$126,783,481
3	ARQT	Arcutis Biotherapeutics, Inc.	1,253,120	$32,856,806
4	ZLAB	Zai Lab Ltd	1,623,694	$30,850,186
5	MANE	Veradermics, Inc	229,581	$28,224,688
6	DFTX	Definium Therapeutics, Inc.	520,108	$24,465,880
7	ROIV	Roivant Sciences Ltd.	125,000	$4,423,750
8	VRTX	Vertex Pharmaceuticals Inc / Ma	6,000	$2,980,380

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$139,316,701	1,989,386	+26425.1%	Shares	Defined	2026-08-14
2023-12-31	$745,875	7,500	-98.2%	Shares	Defined	2024-02-14
2023-09-30	$44,091,299	426,869	+4863.6%	Shares	Defined	2023-11-14
2023-06-30	$1,044,900	8,600	-36.3%	Shares	Defined	2023-08-14
2023-03-31	$2,073,330	13,500	-55.0%	Shares	Defined	2023-05-15
2022-12-31	$5,388,600	30,000	+76.5%	Shares	Defined	2023-02-14
2022-09-30	$2,010,250	17,000	+45.3%	Shares	Defined	2022-11-14
2022-06-30	$1,671,345	11,700	+362.1%	Shares	Defined	2022-08-15
2021-12-31	$643,077	2,532	-94.9%	Shares	Defined	2022-02-14
2021-09-30	$18,985,913	49,332	-24.4%	Shares	Defined	2021-11-12
2021-06-30	$15,339,964	65,282	+47.8%	Shares	Defined	2021-08-13
2021-03-31	$5,785,632	44,182	+1062.7%	Shares	Defined	2021-05-19
2020-12-31	$396,986	3,800	+280.0%	Shares	Defined	2021-02-12
2020-06-30	$64,210	1,000	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.